Furthermore, knockdown of MAPK6 greatly inhibited AKT phosphorylation and H1299 xenograft tumor growth, and overexpression of MAPK6 promoted AKT phosphorylation and PC3 xenograft tumors, demonstrating the tumor-promoting MAPK6-AKT pathway in vivo. Here, MAPK6 is linked to neoplasm.